Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
FGF proteins play broad roles in wound healing

FGF proteins play broad roles in wound healing

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Inadequate management common in young-onset Type 2 diabetes

Inadequate management common in young-onset Type 2 diabetes

Salt poses cardiovascular risk in diabetic patients

Salt poses cardiovascular risk in diabetic patients

Regeneron announces FDA approval of EYLEA Injection for DME treatment

Regeneron announces FDA approval of EYLEA Injection for DME treatment

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

Researchers discover crucial process that regulates development of blood vessels

Researchers discover crucial process that regulates development of blood vessels

CenterVue's next generation Macular Integrity Assessment receives FDA clearance

CenterVue's next generation Macular Integrity Assessment receives FDA clearance

Study shows high BP drugs may raise likelihood of age-related macular degeneration

Study shows high BP drugs may raise likelihood of age-related macular degeneration

Study reveals 70% of patients with diabetic retinopathy will develop macular edema

Study reveals 70% of patients with diabetic retinopathy will develop macular edema

New drug approach for safer clean-up of deformed blood vessels in eye

New drug approach for safer clean-up of deformed blood vessels in eye

Genetic biomarkers of ranibizumab response remain elusive in Koreans with AMD

Genetic biomarkers of ranibizumab response remain elusive in Koreans with AMD

Ranibizumab trial gets promising results for CNV

Ranibizumab trial gets promising results for CNV

Early gene therapy could improve choroideremia prognosis

Early gene therapy could improve choroideremia prognosis

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Scientists examine Gpr109a receptor to find potential treatment for diabetic retinopathy

Scientists examine Gpr109a receptor to find potential treatment for diabetic retinopathy

Three Johns Hopkins researchers awarded grants for work on potential treatments for diabetes

Three Johns Hopkins researchers awarded grants for work on potential treatments for diabetes

Discovery could have far-reaching implications for diagnosis and treatment of diabetic retinopathy

Discovery could have far-reaching implications for diagnosis and treatment of diabetic retinopathy

Interarm blood pressure measurement advised for diabetic patients

Interarm blood pressure measurement advised for diabetic patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.